Anti-Rheumatic Rx

      Does Hydroxychloroquine Hurt the Heart? Dr. Jonathan Kay
      4 years 11 months ago

      Boston-based rheumatologist Dr. Jonathan Kay examines an ACR 2020 study (abstract #0431) looking at whether hydroxychloroquine use has injured patients' hearts.

      Methotrexate and Nonalcoholic Fatty Liver Disease: Dr Eric Dein (@ejdein1)
      Dr. Eric Dein discusses the findings of abstr

      Dr. John Cush RheumNow

      4 years 11 months ago
      Methotrexate and Nonalcoholic Fatty Liver Disease: Dr Eric Dein (@ejdein1) Dr. Eric Dein discusses the findings of abstract #0181 at the #ACR20 annual meeting. https://t.co/TzbRRbw1Kf https://t.co/vK6EahTyQ8
      RT @ejdein1: How do you treat ACPA+, subclinical synovitis (US/MRI+)? Abst#0481 reviews 3 cohorts for progression to cli

      Eric Dein ejdein1

      4 years 11 months ago
      How do you treat ACPA+, subclinical synovitis (US/MRI+)? Abst#0481 reviews 3 cohorts for progression to clinical inflam arthritis. 44-68% did not progress to IA in 1 year, is DMARD over treating? #ACR20 #ACRBest @RheumNow
      Methotrexate and Nonalcoholic Fatty Liver Disease: Dr Eric Dein
      4 years 11 months ago

      Dr. Eric Dein discusses the findings of abstract #0181 at the ACR 2020 annual meeting.

      RT @ejdein1: Who can have sustained DMARD-free remission (SDFR)? Abst#0479 says early DAS response after DMARD initiatio

      Eric Dein ejdein1

      4 years 11 months ago
      Who can have sustained DMARD-free remission (SDFR)? Abst#0479 says early DAS response after DMARD initiation in ACPA-negative patients #ACR20 @RheumNow. Who do you try for DMARD-free intervals? https://t.co/EOfPt4YQAu
      RT @MeralElRamahiMD: Perform (annual) skin exams in patients in MTX based on discovery of a new adverse effect signal wi

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 11 months ago
      Perform (annual) skin exams in patients in MTX based on discovery of a new adverse effect signal with use of low dose MTX (median dose 15 mg/wk) with a NNH of 167! Screening 160 RA patients on MTX will identify 1 skin Ca. Amazing #ACR20 Year in Review by @JYazdanyMD. @RheumNow https://t.co/hUCzKSYZnB
      RT @Janetbirdope: #hydroxychloroquine is not a ‘cutie’ drug. E Park et al showed that HCQ does not increase QT inter

      Janet Pope Janetbirdope

      4 years 11 months ago
      #hydroxychloroquine is not a ‘cutie’ drug. E Park et al showed that HCQ does not increase QT interval in RA & SLE patients including if on other meds that may affect QT but known heart disease excluded from study #ACR20 #ACR2020 @RheumNow abstr#432 @CRASCRRheum https://t.co/FGVPknmj5q
      RT @ejdein1: Abst#0181 out of Korea shows MTX use does not increase prevalence of hepatic steatosis. Encouraging data, t

      Eric Dein ejdein1

      4 years 11 months ago
      Abst#0181 out of Korea shows MTX use does not increase prevalence of hepatic steatosis. Encouraging data, though retrospective study may underpin provider bias in riskier patients. #ACR20 @RheumNow. https://t.co/HeR5hroYUh
      RT @RHEUMarampa: MTX & liver fibrosis:
      71% pts w/low FIB-4i of<1.45
      No correlation bet FIB-4 values & cumul

      sheila RHEUMarampa

      4 years 11 months ago
      MTX & liver fibrosis: 71% pts w/low FIB-4i of<1.45 No correlation bet FIB-4 values & cumulative MTX dose Cumulative MTX dose not sig. ⬆ in pts with FIB-4i >1.45 @RheumNow #ACR20 Abstr#0205 https://t.co/RmyAz9M5fw
      HCQ Not Associated with QTc Length in SLE and RA Patients: Dr. Janet Pope
      4 years 11 months ago

      Dr. Janet Pope discusses abstract #0431 presented Friday at the ACR 2020 virtual meeting.

      RT @drdavidliew: When prescribing hydroxychloroquine for RA, SLE, or other rheumatic diseases, do you routinely order an

      David Liew drdavidliew

      4 years 11 months ago
      When prescribing hydroxychloroquine for RA, SLE, or other rheumatic diseases, do you routinely order an EKG (either before or during)? #ACR20 @RheumNow
      RT @RichardPAConway: Dr Choi et al case control study of methotrexate in RA. No increased risk of NAFLD seen. Increased

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr Choi et al case control study of methotrexate in RA. No increased risk of NAFLD seen. Increased trigs and BMI associated NAFLD @rheumnow #ACR20 Abstr#0181 https://t.co/WLPuf6Ga1D
      Global Rheumatology Alliance Panel
      4 years 11 months ago

      Dr. Kathryn Dao interviews Dr. Jinoos Yazdany, Dr. Philip Robinson and Dr. Jean Liew with the Global Rheumatology Alliance.

      RT @drpnash: Association of Hydroxychloroquine Use with Development of Non-Alcoholic Fatty Liver Disease in Rheumatoid A

      Peter Nash drpnash

      4 years 11 months ago
      Association of Hydroxychloroquine Use with Development of Non-Alcoholic Fatty Liver Disease in Rheumatoid Arthritis https://t.co/3PrWlIGnB8 #RA #HCO #NASH - HCO decreases fatty liver
      RT @lexmeara: COVID-19 use of dexamethasone- why does it work? When to use it ?Is it hyperferrintemic sepsis? Vs early M

      alexa meara lexmeara

      4 years 11 months ago
      COVID-19 use of dexamethasone- why does it work? When to use it ?Is it hyperferrintemic sepsis? Vs early MAS vs? More data needed but this why rheumatologists are needed!!! @RheumNow #ACR20 thank you dr. Rubin! https://t.co/MvQJGqsqu2

      Catch up on Conference Podcasts

      ×